Bausch Health downgraded to Neutral from Overweight at Piper Sandler
January 22, 2021 at 08:34 AM EST
Piper Sandler analyst David Amsellem downgraded Bausch Health to Neutral from Overweight with a price target of $30, up from $25.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|